ESMO 2012 News

Welcome to ESMO 2012 news. Here you will find a selection of articles that appeared in the ESMO 2012 newspaper, Congress Daily, which was distributed to attendees of the ESMO congress in Vienna.

Complete copies of the four newspapers are available for download as PDF files

Filter

Date Title Topic
01 Oct 2012 Targeting the cancer microenvironment Anticancer agents & Biologic therapy
01 Oct 2012 Continuation of bevacizumab beyond progression improves outcome in patients with metastatic colorectal cancer Gastrointestinal cancers
01 Oct 2012 PHARE trial results comparing 6 to 12 months of adjuvant trastuzumab in early breast cancer Breast cancer
01 Oct 2012 First results of TURANDOT Trial Breast cancer
01 Oct 2012 New weapons in the fight against cancer
01 Oct 2012 How to hunt for a primary tumour site Personalised medicine
01 Oct 2012 A step forward in personalised medicine in breast cancer Breast cancer
01 Oct 2012 Successes and failures: Do targeted therapies live up to their promise? Anticancer agents & Biologic therapy
01 Oct 2012 New trial results on pazopanib have important implications for patients with advanced renal cell carcinoma Gastrointestinal cancers
01 Oct 2012 Adding cetuximab to adjuvant chemotherapy offers no benefit to patients with resected stage III colon cancer Gastrointestinal cancers
01 Oct 2012 Updated results of HERA study: Extending trastuzumab for 2 years does not improve outcomes versus 1-year treatment Breast cancer
01 Oct 2012 Characterizing the ALK-positive NSCLC population in Europe Lung and other thoracic tumours
01 Oct 2012 Bone treatments: What to use and when Genitourinary cancers
01 Oct 2012 PM01183: A promising new drug for ovarian cancer Genitourinary cancers
01 Oct 2012 Education Sessions: Key learning points from Sunday Palliative and supportive care - Haematologic malignancies